Skip to main content
. 2015 Mar 25;6(11):8579–8592. doi: 10.18632/oncotarget.3287

Table 2. Associations of LINC00472 with Breast Cancer Survival in Turin Study.

Unadjusted Cox Regression Model
LincRNA HR1 for relapse 95% CI2 p value HR for death 95% CI p value
 Low 1 1
 Mid 0.55 0.34–0.88 0.012 0.47 0.27–0.81 0.006
 High 0.28 0.14–0.58 < 0.001 0.34 0.16–0.72 0.005
 Continuous 0.54 0.39–0.74 <0.001 0.55 0.38–0.80 0.002
Adjusted Cox Regression Model*
LincRNA HR for relapse 95% CI p value HR for death 95% CI p value
 Low 1 1
 Mid 0.82 0.48–1.39 0.45 0.62 0.33–1.16 0.134
 High 0.44 0.20–0.97 0.043 0.51 0.21–1.22 0.129
 Continuous 0.70 0.48–1.00 0.050 0.69 0.45–1.07 0.098
*

Adjusted for age, stage, grade, histology, ER, PR, nodal status and adjuvant treatment.

1

HR: Hazards Ratio

2

CI: Confidence Interval